| - GRCh37:
- Chr2:48033619-48033620
- GRCh38:
- Chr2:47806480-47806481
| MSH6 | Q1280fs, Q1150fs, Q978fs | Endometrial carcinoma, Mismatch repair cancer syndrome 3, Lynch syndrome 5, Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome | Pathogenic/Likely pathogenic (Oct 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:48027806
- GRCh38:
- Chr2:47800667
| MSH6 | T593R, T765R, T895R | Endometrial carcinoma, Lynch syndrome 5, Mismatch repair cancer syndrome 3, Hereditary nonpolyposis colorectal neoplasms | Uncertain significance (Oct 19, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:48033943-48033944
- GRCh38:
- Chr2:47806804-47806805
| MSH6 | | Endometrial carcinoma, Mismatch repair cancer syndrome 3, Lynch syndrome 5, Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome | Uncertain significance (Aug 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:48023164
- GRCh38:
- Chr2:47796025
| MSH6 | D197H | Endometrial carcinoma, Lynch syndrome 5, Mismatch repair cancer syndrome 3, Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome | Conflicting interpretations of pathogenicity (Nov 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:48032740
- GRCh38:
- Chr2:47805601
| MSH6 | | Hereditary cancer-predisposing syndrome, Mismatch repair cancer syndrome 3, Endometrial carcinoma, Lynch syndrome 5 | Likely benign (Mar 31, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:48030637
- GRCh38:
- Chr2:47803498
| MSH6 | D1084G, D782G, D954G | Hereditary cancer-predisposing syndrome, MSH6-related condition, Lynch syndrome 5, Mismatch repair cancer syndrome 3, Endometrial carcinoma, Hereditary nonpolyposis colorectal neoplasms
| Uncertain significance (Sep 8, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:48030727
- GRCh38:
- Chr2:47803588
| MSH6 | L1114Q, L812Q, L984Q | Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, Mismatch repair cancer syndrome 3, Lynch syndrome 5, Endometrial carcinoma, not provided
| Uncertain significance (Mar 14, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:48010592
- GRCh38:
- Chr2:47783453
| MSH6 | G74* | Hereditary cancer-predisposing syndrome, Mismatch repair cancer syndrome 3, Lynch syndrome 5, Endometrial carcinoma, Hereditary nonpolyposis colorectal neoplasms | Pathogenic (Oct 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:48028136
- GRCh38:
- Chr2:47800997
| MSH6 | R1005L, R875L, R703L | Hereditary cancer-predisposing syndrome, Mismatch repair cancer syndrome 3, Endometrial carcinoma, Lynch syndrome 5, Hereditary nonpolyposis colorectal neoplasms | Uncertain significance (Jul 29, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:48027863
- GRCh38:
- Chr2:47800724
| MSH6 | T914I, T612I, T784I | Mismatch repair cancer syndrome 3, Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome
| Conflicting interpretations of pathogenicity (Aug 10, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:48018167
- GRCh38:
- Chr2:47791028
| MSH6 | R121H | Lynch syndrome 5, Endometrial carcinoma, Mismatch repair cancer syndrome 3, Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms, not provided
| Conflicting interpretations of pathogenicity (Jun 13, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:48033435
- GRCh38:
- Chr2:47806296
| MSH6 | T1247A, T945A, T1117A | Lynch syndrome 5, Endometrial carcinoma, Mismatch repair cancer syndrome 3, Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms, not provided
| Uncertain significance (Dec 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:48032807
- GRCh38:
- Chr2:47805668
| MSH6 | H1203N, H1073N, H901N | Hereditary nonpolyposis colorectal neoplasms, not provided, Hereditary cancer-predisposing syndrome, Mismatch repair cancer syndrome 3, Endometrial carcinoma, Lynch syndrome 5
| Conflicting interpretations of pathogenicity (Mar 2, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:48032786
- GRCh38:
- Chr2:47805647
| MSH6 | E1196Q, E1066Q, E894Q | Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, not provided, Mismatch repair cancer syndrome 3, Endometrial carcinoma, Lynch syndrome 5
| Conflicting interpretations of pathogenicity (Apr 26, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:48026660
- GRCh38:
- Chr2:47799521
| MSH6 | I513T, I211T, I383T | Hereditary cancer-predisposing syndrome, not provided, Hereditary nonpolyposis colorectal neoplasms, Mismatch repair cancer syndrome 3, Endometrial carcinoma, Lynch syndrome 5
| Uncertain significance (Oct 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:48030583-48030597
- GRCh38:
- Chr2:47803444-47803458
| MSH6 | | Hereditary nonpolyposis colorectal neoplasms, Endometrial carcinoma, Mismatch repair cancer syndrome 3, Lynch syndrome 5 | Uncertain significance (Dec 10, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:48033511
- GRCh38:
- Chr2:47806372
| MSH6 | | Hereditary nonpolyposis colorectal neoplasms, Breast and/or ovarian cancer, not specified, Lynch syndrome 5, Endometrial carcinoma, Mismatch repair cancer syndrome 3, Hereditary cancer-predisposing syndrome | Benign/Likely benign (Aug 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:48028192
- GRCh38:
- Chr2:47801053
| MSH6 | R1024W, R894W, R722W | Hereditary cancer-predisposing syndrome, Mismatch repair cancer syndrome 3, Lynch syndrome 5, Endometrial carcinoma, Hereditary nonpolyposis colorectal neoplasms, not provided
| Conflicting interpretations of pathogenicity (Apr 18, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:48026471-48026472
- GRCh38:
- Chr2:47799332-47799333
| MSH6 | F321fs, F451fs, F149fs | Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 5, Mismatch repair cancer syndrome 3, Lynch syndrome 5, Endometrial carcinoma, Hereditary cancer-predisposing syndrome
| Pathogenic/Likely pathogenic (Mar 28, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:48027220
- GRCh38:
- Chr2:47800081
| MSH6 | L700I, L570I, L398I | Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, Endometrial carcinoma, Mismatch repair cancer syndrome 3, Lynch syndrome 5, Lynch syndrome
| Uncertain significance (Oct 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:48027790
- GRCh38:
- Chr2:47800651
| MSH6 | V890F, V588F, V760F | Endometrial carcinoma, Mismatch repair cancer syndrome 3, Lynch syndrome 5, Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, not specified
| Conflicting interpretations of pathogenicity (May 31, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:48033438
- GRCh38:
- Chr2:47806299
| MSH6 | H1248Y, H946Y, H1118Y | Endometrial carcinoma, Mismatch repair cancer syndrome 3, Lynch syndrome 5, Hereditary nonpolyposis colorectal neoplasms, not provided, Hereditary cancer-predisposing syndrome
| Uncertain significance (Nov 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:48033944
- GRCh38:
- Chr2:47806805
| MSH6 | S1343*, S1041*, S1213* | Lynch syndrome 5, Endometrial carcinoma, Mismatch repair cancer syndrome 3, Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms | Uncertain significance (Oct 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:48033988
- GRCh38:
- Chr2:47806849
| MSH6 | K1358E, K1228E, K1056E | Endometrial carcinoma, Lynch syndrome 5, Mismatch repair cancer syndrome 3, Lynch syndrome 1 | Uncertain significance (Oct 31, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:48030614
- GRCh38:
- Chr2:47803475
| MSH6 | | Hereditary cancer-predisposing syndrome, Mismatch repair cancer syndrome 3, Endometrial carcinoma, Lynch syndrome 5 | Likely benign (Apr 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:48010382
- GRCh38:
- Chr2:47783243
| MSH6 | Q4* | Endometrial carcinoma, Mismatch repair cancer syndrome 3, Lynch syndrome 5, Breast and/or ovarian cancer, MSH6-related condition, Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome, not provided, Lynch syndrome 5 | Pathogenic/Likely pathogenic (Mar 28, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:48033802-48033805
- GRCh38:
- Chr2:47806652-47806653
| MSH6 | | Endometrial carcinoma, Mismatch repair cancer syndrome 3, Lynch syndrome 5, Hereditary nonpolyposis colorectal neoplasms, not specified, Hereditary cancer-predisposing syndrome, not provided, Lynch syndrome 5 | Benign/Likely benign (Aug 15, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:48026312
- GRCh38:
- Chr2:47799173
| MSH6 | Y397C, Y267C, Y95C | Hereditary nonpolyposis colorectal neoplasms, Mismatch repair cancer syndrome 3, Lynch syndrome 5, Endometrial carcinoma, Hereditary cancer-predisposing syndrome, not specified, Lynch syndrome, Hereditary breast ovarian cancer syndrome, Lynch syndrome 5, not provided | Conflicting interpretations of pathogenicity (Sep 18, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:48025953
- GRCh38:
- Chr2:47798814
| MSH6 | E277D, E147D | Endometrial carcinoma, Lynch syndrome 5, Mismatch repair cancer syndrome 3, Hereditary nonpolyposis colorectal neoplasms, MSH6-related condition, Hereditary cancer-predisposing syndrome, not provided, not specified, Lynch syndrome 5
| Conflicting interpretations of pathogenicity (Sep 6, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:48027775
- GRCh38:
- Chr2:47800636
| MSH6 | K885*, K755*, K583* | Hereditary nonpolyposis colorectal neoplasms, Mismatch repair cancer syndrome 3, Hereditary cancer-predisposing syndrome, not provided | Pathogenic (Aug 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:48033991-48033992
- GRCh38:
- Chr2:47806852-47806853
| MSH6 | | MSH6-related condition, Endometrial carcinoma, Lynch syndrome 5, Mismatch repair cancer syndrome 3, Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, not specified, not provided, Lynch syndrome 5
| Uncertain significance (Aug 15, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:48028314
- GRCh38:
- Chr2:47801175
| MSH6 | | Endometrial carcinoma, Mismatch repair cancer syndrome 3, Lynch syndrome 5, Hereditary nonpolyposis colorectal neoplasms, Breast and/or ovarian cancer, Hereditary cancer-predisposing syndrome, not specified | Benign/Likely benign (Aug 15, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:48025928
- GRCh38:
- Chr2:47798789
| MSH6 | T269S, T139S | Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, not specified, not provided, Endometrial carcinoma, Lynch syndrome 5, Mismatch repair cancer syndrome 3 | Conflicting interpretations of pathogenicity (Aug 15, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:48025782
- GRCh38:
- Chr2:47798643
| MSH6 | E220D, E90D | Lynch syndrome | Likely benign (Sep 5, 2013) | reviewed by expert panel |
| - GRCh37:
- Chr2:48025764
- GRCh38:
- Chr2:47798625
| MSH6 | Y214*, Y84* | Lynch syndrome | Pathogenic (Sep 5, 2013) | reviewed by expert panel |
| - GRCh37:
- Chr2:48033792-48033795
- GRCh38:
- Chr2:47806653-47806656
| MSH6 | | Lynch syndrome | Likely benign (Jun 21, 2019) | reviewed by expert panel |
| - GRCh37:
- Chr2:48033727-48033728
- GRCh38:
- Chr2:47806588-47806589
| MSH6 | | Lynch syndrome | Pathogenic (Sep 5, 2013) | reviewed by expert panel |
| - GRCh37:
- Chr2:48032740-48032741
- GRCh38:
- Chr2:47805601-47805602
| MSH6 | | Lynch syndrome | Benign (Sep 5, 2013) | reviewed by expert panel |
| - GRCh37:
- Chr2:48032048
- GRCh38:
- Chr2:47804909
| MSH6 | | Lynch syndrome | Likely pathogenic (Jun 21, 2019) | reviewed by expert panel |
| - GRCh37:
- Chr2:48032033
- GRCh38:
- Chr2:47804894
| MSH6 | | Lynch syndrome | Benign (Sep 5, 2013) | reviewed by expert panel |
| - GRCh37:
- Chr2:48030772-48030774
- GRCh38:
- Chr2:47803633-47803635
| MSH6 | | Mismatch repair cancer syndrome 3 | Pathogenic (Jan 1, 2004) | no assertion criteria provided |
| - GRCh37:
- Chr2:48030639-48030640
- GRCh38:
- Chr2:47803500-47803501
| MSH6 | F1088fs, F786fs, F958fs | Lynch syndrome | Pathogenic (Sep 5, 2013) | reviewed by expert panel |
| - GRCh37:
- Chr2:48030640
- GRCh38:
- Chr2:47803501
| MSH6 | F958fs, F786fs | Lynch syndrome | Pathogenic (Sep 5, 2013) | reviewed by expert panel |
| - GRCh37:
- Chr2:48028225
- GRCh38:
- Chr2:47801086
| MSH6 | R1035*, R733*, R905* | Lynch syndrome | Pathogenic (Sep 5, 2013) | reviewed by expert panel |
| - GRCh37:
- Chr2:48028142
- GRCh38:
- Chr2:47801003
| MSH6 | W1007*, W705*, W877* | Lynch syndrome | Pathogenic (Sep 5, 2013) | reviewed by expert panel |
| - GRCh37:
- Chr2:48027853
- GRCh38:
- Chr2:47800714
| MSH6 | R911*, R609*, R781* | Lynch syndrome | Pathogenic (Sep 5, 2013) | reviewed by expert panel |
| - GRCh37:
- Chr2:48027269-48027272
- GRCh38:
- Chr2:47800130-47800133
| MSH6 | V415fs, V587fs | Lynch syndrome | Pathogenic (Sep 5, 2013) | reviewed by expert panel |
| - GRCh37:
- Chr2:48027227
- GRCh38:
- Chr2:47800088
| MSH6 | S702*, S400*, S572* | Lynch syndrome | Pathogenic (Sep 5, 2013) | reviewed by expert panel |
| - GRCh37:
- Chr2:48026861
- GRCh38:
- Chr2:47799722
| MSH6 | S580L, S278L, S450L | Mismatch repair cancer syndrome 3, Endometrial carcinoma, Lynch syndrome 5, Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, not provided, not specified | Conflicting interpretations of pathogenicity (Mar 21, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:48026630
- GRCh38:
- Chr2:47799491
| MSH6 | S201C, S373C | Lynch syndrome | Likely benign (Sep 5, 2013) | reviewed by expert panel |
| - GRCh37:
- Chr2:48033780
- GRCh38:
- Chr2:47806641
| MSH6 | R1331*, R1029*, R1201* | Lynch syndrome | Pathogenic (Sep 5, 2013) | reviewed by expert panel |
| - GRCh37:
- Chr2:48030838
- GRCh38:
- Chr2:47803699
| MSH6 | | Lynch syndrome | Benign (Sep 5, 2013) | reviewed by expert panel |
| - GRCh37:
- Chr2:48026648
- GRCh38:
- Chr2:47799509
| MSH6 | V509A, V207A, V379A | Lynch syndrome | Likely benign (Sep 5, 2013) | reviewed by expert panel |
| - GRCh37:
- Chr2:48025764
- GRCh38:
- Chr2:47798625
| MSH6 | | Lynch syndrome | Benign (Sep 5, 2013) | reviewed by expert panel |
| - GRCh37:
- Chr2:48023115
- GRCh38:
- Chr2:47795976
| MSH6 | | Lynch syndrome | Benign (Sep 5, 2013) | reviewed by expert panel |
| - GRCh37:
- Chr2:48025772-48025773
- GRCh38:
- Chr2:47798633-47798634
| MSH6 | K88*, K218* | Lynch syndrome | Pathogenic (Sep 5, 2013) | reviewed by expert panel |
| - GRCh37:
- Chr2:48027755
- GRCh38:
- Chr2:47800616
| MSH6 | V878A, V576A, V748A | Lynch syndrome | Benign (Sep 5, 2013) | reviewed by expert panel |